Here is a breakdown of key second quarter results published by SeaSpine, Orthofix and Smith+Nephew, along with the year-over-year percentage change:
SeaSpine
Net sales: $47.5 million (+66 percent)
U.S. sales: $42.6 million (+64 percent)
U.S. spinal implants and enabling technologies sales: $21.4 million (+62 percent)
U.S. orthobiologics sales: $21.2 million (+67 percent)
Orthofix
Net sales: $121 million (+66 percent)
Global spine sales: $94.7 million (+62.5 percent)
Global orthopedic sales: $26.7 million (+66 percent)
Smith+Nephew
Net sales: $1.3 million (+48.2 percent)
Orthopedic sales: $557 million (+53 percent)
Knee sales: $226 million (+65.5 percent)
Hip sales: $161 million (+43.6 percent)
Trauma and extremities sales: $149 milloin (+44.3 percent)
Sports medicine joint repair sales: $211 million (+63.6 percent)